Serum Amyloid A is a Better Predictor of Clinical Outcomes than C-Reactive Protein in Non-ST-Segment Elevation Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Serum Amyloid A is a Better Predictor of Clinical Outcomes than C-Reactive Protein in Non-ST-Segment Elevation Acute Coronary Syndromes

Published:2007 Issue:2 Volume:71 Page:186-190
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kosuge Masami¹,Ebina Toshiaki¹,Ishikawa Toshiyuki¹,Hibi Kiyoshi¹,Tsukahara Kengo¹,Okuda Jyun¹,Iwahashi Noriaki¹,Ozaki Hiroyuki¹,Yano Hideto¹,Kusama Ikuyoshi¹,Nakati Tastuya¹,Umemura Satoshi¹,Kimura Kazuo¹

Affiliation:

1. Division of Cardiology, Yokohama City University Medical Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/71/2/71_2_186/_pdf

Reference28 articles.

1. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA–KORA Augsburg Cohort Study 1984–1998

2. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

3. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease

4. C-Reactive Protein Increase in Unstable Coronary Disease

5. Relation of Number of Complex Coronary Lesions to Serum C-Reactive Protein Levels and Major Adverse Cardiovascular Events at One Year

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Podoplanin Positive Cell-derived Extracellular Vesicles Contribute to Cardiac Amyloidosis After Myocardial Infarction;2024-07-03

2. Osteocytes/Osteoblasts Produce SAA3 to Regulate Hepatic Metabolism of Cholesterol;Advanced Science;2024-04-13

3. Preoperative risk factors associated with left ventricular dysfunction after bariatric surgery;Scientific Reports;2024-01-25

4. Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results;Frontiers in Cardiovascular Medicine;2024-01-08

5. Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease;Expert Review of Cardiovascular Therapy;2023-10-03